These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1112 related articles for article (PubMed ID: 30704460)

  • 1. Integration of genomic copy number variations and chemotherapy-response biomarkers in pediatric sarcoma.
    Cheng L; Pandya PH; Liu E; Chandra P; Wang L; Murray ME; Carter J; Ferguson M; Saadatzadeh MR; Bijangi-Visheshsaraei K; Marshall M; Li L; Pollok KE; Renbarger JL
    BMC Med Genomics; 2019 Jan; 12(Suppl 1):23. PubMed ID: 30704460
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of Novel Tyrosine Kinase Fusion Genes as Potential Therapeutic Targets in Bone and Soft Tissue Sarcomas Using DNA/RNA-based Clinical Sequencing.
    Hasegawa N; Hayashi T; Niizuma H; Kikuta K; Imanishi J; Endo M; Ikeuchi H; Sasa K; Sano K; Hirabayashi K; Takagi T; Ishijima M; Kato S; Kohsaka S; Saito T; Suehara Y
    Clin Orthop Relat Res; 2024 Mar; 482(3):549-563. PubMed ID: 38014853
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical genomic profiling to identify actionable alterations for investigational therapies in patients with diverse sarcomas.
    Groisberg R; Hong DS; Holla V; Janku F; Piha-Paul S; Ravi V; Benjamin R; Kumar Patel S; Somaiah N; Conley A; Ali SM; Schrock AB; Ross JS; Stephens PJ; Miller VA; Sen S; Herzog C; Meric-Bernstam F; Subbiah V
    Oncotarget; 2017 Jun; 8(24):39254-39267. PubMed ID: 28424409
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and validation of prognostic markers in sarcomas base on a multi-omics analysis.
    Song Y; Yang K; Sun T; Tang R
    BMC Med Genomics; 2021 Jan; 14(1):31. PubMed ID: 33509178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fluorescence in Situ Hybridization (FISH) for Differential Diagnosis of Soft Tissue Sarcomas.
    Asif A; Mushtaq S; Hassan U; Akhtar N; Hussain M; Azam M; Qazi R
    Asian Pac J Cancer Prev; 2018 Mar; 19(3):655-660. PubMed ID: 29580035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targetable Alterations in Adult Patients With Soft-Tissue Sarcomas: Insights for Personalized Therapy.
    Lucchesi C; Khalifa E; Laizet Y; Soubeyran I; Mathoulin-Pelissier S; Chomienne C; Italiano A
    JAMA Oncol; 2018 Oct; 4(10):1398-1404. PubMed ID: 29801054
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of Predictive Biomarkers of the Response to Pazopanib Based on an Integrative Analysis of High-grade Soft-tissue Sarcomas: Analysis of a Tumor Sample from a Responder and Patients with Other Soft-tissue Sarcomas.
    Suehara Y; Kohsaka S; Yamaguchi S; Hayashi T; Kurihara T; Sano K; Sasa K; Akaike K; Ueno T; Kojima S; Ikegami M; Mizuno S; Okubo T; Kim Y; Kaneko K; Saito T; Kato S; Mano H
    Clin Orthop Relat Res; 2020 Nov; 478(11):2461-2476. PubMed ID: 32567826
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Prognostic Molecular Signature of N⁶-Methyladenosine Methylation Regulators for Soft-Tissue Sarcoma from The Cancer Genome Atlas Database.
    Hou M; Guo X; Chen Y; Cong L; Pan C
    Med Sci Monit; 2020 Dec; 26():e928400. PubMed ID: 33370249
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of molecular cytogenetic alteration in rhabdomyosarcoma by array comparative genomic hybridization.
    Liu C; Li D; Jiang J; Hu J; Zhang W; Chen Y; Cui X; Qi Y; Zou H; Zhang W; Li F
    PLoS One; 2014; 9(4):e94924. PubMed ID: 24743780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multi-omics analysis of copy number variations of RNA regulatory genes in soft tissue sarcoma.
    Wang X; Han Y; Li J; Hong D; Xue Z; Huang H; Du Z; Hou Y; Li H; Li H; Liao H; Xie X; Ding C
    Life Sci; 2021 Jan; 265():118734. PubMed ID: 33166590
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pediatric BCOR-Altered Tumors From Soft Tissue/Kidney Display Specific DNA Methylation Profiles.
    Salgado CM; Alaggio R; Ciolfi A; Zin A; Diomedi Camassei F; Pedace L; Milano GM; Serra A; Di Giannatale A; Mastronuzzi A; Gianatti A; Bisogno G; Ferrari A; Tartaglia M; Reyes-Múgica M; Locatelli F; Miele E
    Mod Pathol; 2023 Feb; 36(2):100039. PubMed ID: 36853789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Copy number variation in Fayoumi and Leghorn chickens analyzed using array comparative genomic hybridization.
    Abernathy J; Li X; Jia X; Chou W; Lamont SJ; Crooijmans R; Zhou H
    Anim Genet; 2014 Jun; 45(3):400-11. PubMed ID: 24628374
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrated analysis of gene expression and genomic aberration data in osteosarcoma (OS).
    Xiong Y; Wu S; Du Q; Wang A; Wang Z
    Cancer Gene Ther; 2015 Nov; 22(11):524-9. PubMed ID: 26427513
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular signatures of BRCAness analysis identifies PARP inhibitor Niraparib as a novel targeted therapeutic strategy for soft tissue Sarcomas.
    Li H; Tu J; Zhao Z; Chen L; Qu Y; Li H; Yao H; Wang X; Lee DF; Shen J; Wen L; Huang G; Xie X
    Theranostics; 2020; 10(21):9477-9494. PubMed ID: 32863940
    [No Abstract]   [Full Text] [Related]  

  • 15. Undifferentiated Sarcomas in Children Harbor Clinically Relevant Oncogenic Fusions and Gene Copy-Number Alterations: A Report from the Children's Oncology Group.
    Laetsch TW; Roy A; Xu L; Black JO; Coffin CM; Chi YY; Tian J; Spunt SL; Hawkins DS; Bridge JA; Parsons DW; Skapek SX
    Clin Cancer Res; 2018 Aug; 24(16):3888-3897. PubMed ID: 29691299
    [No Abstract]   [Full Text] [Related]  

  • 16. Loss of Chromosome 3q Is a Prognostic Marker in Fusion-Negative Rhabdomyosarcoma.
    Dehner CA; Bell RC; Cao Y; He K; Chrisinger JSA; Armstrong AE; Yohe M; Shern J; Hirbe AC
    JCO Precis Oncol; 2023 Sep; 7():e2300037. PubMed ID: 37738543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genomic Insights Into High-Grade Infarct-Associated Bone Sarcomas.
    Tvrdik T; Gjeorgjievski SG; Wong P; Oskouei S; Read W; Bahrami A
    Mod Pathol; 2024 Oct; 37(10):100572. PubMed ID: 39033963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relapsed diffuse large B-cell lymphoma present different genomic profiles between early and late relapses.
    Broséus J; Chen G; Hergalant S; Ramstein G; Mounier N; Guéant JL; Feugier P; Gisselbrecht C; Thieblemont C; Houlgatte R
    Oncotarget; 2016 Dec; 7(51):83987-84002. PubMed ID: 27276707
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chromosome instability accounts for reverse metastatic outcomes of pediatric and adult synovial sarcomas.
    Lagarde P; Przybyl J; Brulard C; Pérot G; Pierron G; Delattre O; Sciot R; Wozniak A; Schöffski P; Terrier P; Neuville A; Coindre JM; Italiano A; Orbach D; Debiec-Rychter M; Chibon F
    J Clin Oncol; 2013 Feb; 31(5):608-15. PubMed ID: 23319690
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elucidating the transcriptional program of feline injection-site sarcoma using a cross-species mRNA-sequencing approach.
    Wei Q; Ramsey SA; Larson MK; Berlow NE; Ochola D; Shiprack C; Kashyap A; Séguin B; Keller C; Löhr CV
    BMC Cancer; 2019 Apr; 19(1):311. PubMed ID: 30947707
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 56.